In this section:

30 March 2020

PsoProtect: a new psoriasis and COVID-19 patient registry

The Psoriasis Association are pleased to announce their support for PsoProtect.

The Psoriasis Association are pleased to announce their support for PsoProtect, an international registry where health care professionals can report outcomes of COVID-19 infection in people with psoriasis.

PsoProtect (website news)PsoProtect has been set up by world-leading psoriasis researchers at Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and the University of Manchester to capture de-identified information about the outcomes and experiences of individuals with psoriasis who have had COVID-19. This will provide real world information for clinicians to help them assess risk in people with psoriasis. The registry will also help researchers to investigate whether different medicines or co-morbidities of psoriasis affect the outcome of COVID-19 infection.

This registry will provide a vital clinical and research resource to help in our collective fight against COVID-19 but please note that the registry is for clinicians to submit de-identified data, not patients. However, if you or a family member with psoriasis have had, or get Coronavirus, please do ask your clinician to submit your data to PsoProtect.

PsoProtect will publish regular summaries and insights from the registry, however, they are unable to provide information on request. The latest data can be found here.

In October 2020, the first findings from PsoProtect were published. You can find out more here.

For the most up-to-date advice on COVID-19 (Coronavirus), you should:

  1. Read the guidance on the NHS website
  2. Read the guidance on the Public Health England website

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you. If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them. Close